Tacrolimus is used for: Prophylaxis of rejection in kidney; liver & cardiac graft transplant.
Recorded in the NepalDoc medicine catalog for Tacrolimus.
Tacrolimus capsules are a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver, kidney, or heart transplants, and pediatric patients receiving allogenic liver transplants in combination with other immunosuppressants.
From the U.S. FDA-approved label for Tacrolimus. Full label: DailyMed.
Tacrolimus capsules are a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver, kidney, or heart transplants, and pediatric patients receiving allogenic liver transplants in combination with other immunosuppressants. Additional pediatric use information is approved for Astellas Pharma US, Inc.’s Prograf (tacrolimus) products. However, due to Astellas Pharma US, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.
From the U.S. FDA-approved label for Tacrolimus. Full label: DailyMed.
Administer capsules consistently with or without food., Therapeutic drug monitoring is recommended., Avoid eating grapefruit or drinking grapefruit juice., See dosage adjustments for African-American patients, hepatic and renal impaired., For complete dosing information, see Full Prescribing Information. Tacrolimus capsules are not interchangeable or substitutable for other tacrolimus extended-release products. This is because rate of absorption following the administration of an extended-release tacrolimus product is not equivalent to that of an immediate-release tacrolimus drug product.
Directions from the U.S. FDA-approved label for Tacrolimus — your doctor or pharmacist may advise differently.
Tacrolimus capsules are contraindicated in patients with a hypersensitivity to tacrolimus. Hypersensitivity symptoms reported include dyspnea, rash, pruritus, and acute respiratory distress syndrome., Hypersensitivity to tacrolimus or HCO-60 (polyoxyl 60 hydrogenated castor oil).
Excerpt from the U.S. FDA-approved label for Tacrolimus. Talk to a pharmacist or doctor before use.
Not Interchangeable with Extended-Release Tacrolimus Products – Medication Errors: Instruct patients or caregivers to recognize the appearance of tacrolimus capsules., New Onset Diabetes After Transplant: Monitor blood glucose., Nephrotoxicity (acute and/or chronic): Reduce the dose; use caution with other nephrotoxic drugs., Neurotoxicity: Including risk of Posterior Reversible Encephalopathy Syndrome (PRES); monitor for neurologic abnormalities; reduce or discontinue tacrolimus., Hyperkalemia: Monitor serum potassium levels.
Warnings and precautions excerpt from the U.S. FDA-approved label for Tacrolimus — not a complete list. Talk to a pharmacist or doctor before use.
The following serious and otherwise important adverse drug reactions are discussed in greater detail in other sections of labeling: Lymphoma and Other Malignancies, Serious Infections, New Onset Diabetes After Transplant, Nephrotoxicity, Neurotoxicity, Hyperkalemia, Hypertension, Anaphylactic Reactions with Tacrolimus Injection, Myocardial Hypertrophy, Pure Red Cell Aplasia, Thrombotic Microangiopathy, Including Hemolytic…
Excerpt from the U.S. FDA-approved label for Tacrolimus — not a complete list. Talk to a pharmacist or doctor about side effects.
9 brands · 4 makers in the NepalDoc catalog — see the full Tacrolimus guide →
Store and Dispense Tacrolimus capsules, USP should be stored at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Tacrolimus.
What is Seegraf 0.5?
Seegraf 0.5mg Capsule is a Tacrolimus medicine made by Micro Labs Ltd. It comes as 0.5mg Capsule.
What is Seegraf 0.5 used for?
Tacrolimus is used for Prophylaxis of rejection in kidney, liver & cardiac graft transplant.
What is the generic name of Seegraf 0.5?
The generic name of Seegraf 0.5 is Tacrolimus.
Which brands of Tacrolimus are available in Nepal?
9 brands of Tacrolimus are listed in the NepalDoc catalog, from 4 makers — including Pangraf 0.5mg Capsule, Pangraf 1mg Capsule, Pangraf 2mg Tablet, Seegraf 1mg Capsule, Takfa Capsule, Takfa 0.5mg Capsule.
What are the side effects of Tacrolimus?
The following serious and otherwise important adverse drug reactions are discussed in greater detail in other sections of labeling: Lymphoma and Other Malignancies, Serious Infections, New Onset Diabetes After Transplant, Nephrotoxicity, Neurotoxicity, Hyperkalemia, Hypertension, Anaphylactic Reactions with Tacrolimus Injection, Myocardial Hypertrophy, Pure Red Cell Aplasia, Thrombotic Microangiopathy, Including Hemolytic…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
